Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 1;141(1):248-270.
doi: 10.1093/brain/awx317.

The cerebellar cognitive affective/Schmahmann syndrome scale

Affiliations

The cerebellar cognitive affective/Schmahmann syndrome scale

Franziska Hoche et al. Brain. .

Abstract

Cerebellar cognitive affective syndrome (CCAS; Schmahmann's syndrome) is characterized by deficits in executive function, linguistic processing, spatial cognition, and affect regulation. Diagnosis currently relies on detailed neuropsychological testing. The aim of this study was to develop an office or bedside cognitive screen to help identify CCAS in cerebellar patients. Secondary objectives were to evaluate whether available brief tests of mental function detect cognitive impairment in cerebellar patients, whether cognitive performance is different in patients with isolated cerebellar lesions versus complex cerebrocerebellar pathology, and whether there are cognitive deficits that should raise red flags about extra-cerebellar pathology. Comprehensive standard neuropsychological tests, experimental measures and clinical rating scales were administered to 77 patients with cerebellar disease-36 isolated cerebellar degeneration or injury, and 41 complex cerebrocerebellar pathology-and to healthy matched controls. Tests that differentiated patients from controls were used to develop a screening instrument that includes the cardinal elements of CCAS. We validated this new scale in a new cohort of 39 cerebellar patients and 55 healthy controls. We confirm the defining features of CCAS using neuropsychological measures. Deficits in executive function were most pronounced for working memory, mental flexibility, and abstract reasoning. Language deficits included verb for noun generation and phonemic > semantic fluency. Visual spatial function was degraded in performance and interpretation of visual stimuli. Neuropsychiatric features included impairments in attentional control, emotional control, psychosis spectrum disorders and social skill set. From these results, we derived a 10-item scale providing total raw score, cut-offs for each test, and pass/fail criteria that determined 'possible' (one test failed), 'probable' (two tests failed), and 'definite' CCAS (three tests failed). When applied to the exploratory cohort, and administered to the validation cohort, the CCAS/Schmahmann scale identified sensitivity and selectivity, respectively as possible exploratory cohort: 85%/74%, validation cohort: 95%/78%; probable exploratory cohort: 58%/94%, validation cohort: 82%/93%; and definite exploratory cohort: 48%/100%, validation cohort: 46%/100%. In patients in the exploratory cohort, Mini-Mental State Examination and Montreal Cognitive Assessment scores were within normal range. Complex cerebrocerebellar disease patients were impaired on similarities in comparison to isolated cerebellar disease. Inability to recall words from multiple choice occurred only in patients with extra-cerebellar disease. The CCAS/Schmahmann syndrome scale is useful for expedited clinical assessment of CCAS in patients with cerebellar disorders.awx317media15678692096001.

Keywords: behaviour; cerebellar cognitive affective syndrome; cerebellum; cognition; rating scale.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatterplots of performance of patients and controls on cognitive tests in the CCAS/Schmahmann scale. Bold line indicates the threshold value (the cut-off) determining that performance is impaired. Circles = exploratory cohort, crosses = validation cohort. Y-axis represents total raw scores.
Figure 1
Figure 1
Scatterplots of performance of patients and controls on cognitive tests in the CCAS/Schmahmann scale. Bold line indicates the threshold value (the cut-off) determining that performance is impaired. Circles = exploratory cohort, crosses = validation cohort. Y-axis represents total raw scores.
Figure 1
Figure 1
Scatterplots of performance of patients and controls on cognitive tests in the CCAS/Schmahmann scale. Bold line indicates the threshold value (the cut-off) determining that performance is impaired. Circles = exploratory cohort, crosses = validation cohort. Y-axis represents total raw scores.
Figure 2
Figure 2
The cerebellar cognitive affective/Schmahmann syndrome scale (Version 1A). See Supplementary material for administration and scoring instructions, and Versions 1B, 1C, and 1D that have different test items within each domain to facilitate test-rest reliability.
Figure 2
Figure 2
The cerebellar cognitive affective/Schmahmann syndrome scale (Version 1A). See Supplementary material for administration and scoring instructions, and Versions 1B, 1C, and 1D that have different test items within each domain to facilitate test-rest reliability.
Figure 3
Figure 3
Patient performance with verbal instruction to draw a cube (left) and to copy a cube (right).

Comment in

Similar articles

Cited by

References

    1. Adamaszek M, D'agata F, Ferrucci R, Habas C, Keulen S, Kirkby KC, et al.Consensus paper: cerebellum and emotion. Cerebellum 2017; 16: 552–76. - PubMed
    1. Arasanz CP, Staines WR, Roy EA, Schweizer TA. The cerebellum and its role in word generation: a cTBS study. Cortex 2012; 48: 718–24. - PubMed
    1. Benton AL, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment. New York: Oxford University Press; 1983.
    1. Botez MI, Botez T, Elie R, Attig E. Role of the cerebellum in complex human behavior. Ital J Neurol Sci 1989; 10: 291–300. - PubMed
    1. Brandt J, Leroi I, O’Hearn E, Rosenblatt A, Margolis RL. Cognitive impairments in cerebellar degeneration: a comparison with Huntington’s disease. J Neuropsychiatry Clin Neurosci 2004; 16: 176–84. - PubMed

Publication types

MeSH terms